Log In
Print
BCIQ
Print
Print this Print this
 

NS2

  Manage Alerts
Collapse Summary General Information
Company Aldeyra Therapeutics Inc.
DescriptionSmall molecule that traps and allows for the disposal of free aldehydes
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationUveitis
Indication DetailsTreat acute anterior uveitis; Treat non-infectious anterior uveitis
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today